BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,455,066 | -9.3% | 8,704,000 | -8.2% | 0.24% | -4.8% |
Q2 2023 | $9,323,983 | -9.7% | 9,478,000 | -6.1% | 0.25% | -11.1% |
Q1 2023 | $10,326,148 | -9.7% | 10,093,000 | -6.0% | 0.28% | -9.1% |
Q4 2022 | $11,437,353 | -8.5% | 10,733,000 | -14.0% | 0.31% | -13.3% |
Q3 2022 | $12,494,000 | +17.9% | 12,475,000 | +16.6% | 0.35% | +23.3% |
Q2 2022 | $10,595,000 | -27.5% | 10,703,000 | -26.4% | 0.29% | -14.6% |
Q1 2022 | $14,612,000 | +18.9% | 14,548,000 | +24.5% | 0.34% | +34.9% |
Q4 2021 | $12,292,000 | +10.3% | 11,686,000 | +7.8% | 0.25% | +2.5% |
Q3 2021 | $11,147,000 | +257.4% | 10,836,000 | +261.2% | 0.24% | +247.1% |
Q2 2021 | $3,119,000 | +1.7% | 3,000,000 | 0.0% | 0.07% | -2.8% |
Q1 2021 | $3,067,000 | -4.6% | 3,000,000 | 0.0% | 0.07% | -12.2% |
Q4 2020 | $3,216,000 | +54.2% | 3,000,000 | +50.0% | 0.08% | +32.3% |
Q3 2020 | $2,086,000 | -15.2% | 2,000,000 | 0.0% | 0.06% | -20.5% |
Q2 2020 | $2,460,000 | +18.2% | 2,000,000 | 0.0% | 0.08% | +5.4% |
Q1 2020 | $2,081,000 | -1.8% | 2,000,000 | 0.0% | 0.07% | +23.3% |
Q4 2019 | $2,119,000 | +7.7% | 2,000,000 | 0.0% | 0.06% | 0.0% |
Q3 2019 | $1,968,000 | -5.5% | 2,000,000 | 0.0% | 0.06% | -6.2% |
Q2 2019 | $2,082,000 | – | 2,000,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 53,670 | $57,726,000 | 3.34% |
SHENKMAN CAPITAL MANAGEMENT INC | 26,959,000 | $29,149,000 | 3.04% |
ADVENT CAPITAL MANAGEMENT /DE/ | 84,134,000 | $90,539,000 | 1.93% |
Cheyne Capital Management (UK) LLP | 3,220,000 | $3,452,000 | 1.75% |
PFM Health Sciences, LP | 40,300,000 | $43,210,000 | 1.52% |
Sonora Investment Management, LLC | 6,370,000 | $6,807,000 | 0.56% |
MACKAY SHIELDS LLC | 66,018,000 | $70,980,000 | 0.49% |
ZAZOVE ASSOCIATES LLC | 1,500,000 | $1,608,000 | 0.20% |
IRON Financial LLC | 275,000 | $295,000 | 0.15% |
PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $3,216,000 | 0.08% |